Saturday, January 29, 2022
Home Featured


South Korean drug company Hanmi Pharmaceutical is set to release its inhaler asthma medication Glyterol (indacaterol/glycopyrronium bromide) in 2023. It will roll out the drug in Korea after Xoterna Breezhaler’s patent expires next year.
The Global Anxiety Drugs Market report has been released and found that the industry is expected to grow at a CAGR of 8.61% to reach $24.47 billion by 2027. In the United States, the incidence of anxiety disorders has increased, calling for more therapies.
Prescription drug prices continue to hurt Americans with or without health insurance. GoodRx, a healthcare company that tracks prescription drug prices and offers discount coupons, so far, this month, more than 650 prescription drugs have seen a price hike.
For some people in Alabama, skyrocketing prescription drug prices has become a major cause of concern. People are paying a lot for some of the lifesaving prescription drugs even after getting pharmacy discounts. Experts believe Alabama needs new legislation to solve this issue.
A Norwegian ad in which Father Christmas kisses a man waiting for him at home on Christmas Eve has become a surprise hit. The ad highlighted a big shift in Norwegian society. Some appreciated it while others criticized the ad, stating that the idea of gay Santa would be controversial.
Beta Drugs Ltd, an Indian pharmaceutical company, has received approval from the Drugs Controller General of India (DCGI) for its oral azacitidine in the treatment of acute myeloid leukemia. Brand azacitidine injectable manufactured by Celgene under the brand name Vidaza.
Hypertensive drugs do help control your high blood pressure, but there are a few drug-free ways of managing the condition. People with high blood pressure can include foods that are rich In potassium because it eases the effects of sodium.